Therefore, NLRP3 and Caspase-1 gene deletions can interfere with AD’s progression and improve cognitive function by blocking the formation of NLRP3/Caspase--1 inflammatory body [36]. This evidence concerns the gene NLRP3 and Alzheimer disease.